» Articles » PMID: 36127558

Randomization for the Susceptibility Effect of an Infectious Disease Intervention

Overview
Journal J Math Biol
Date 2022 Sep 20
PMID 36127558
Authors
Affiliations
Soon will be listed here.
Abstract

Randomized trials of infectious disease interventions, such as vaccines, often focus on groups of connected or potentially interacting individuals. When the pathogen of interest is transmissible between study subjects, interference may occur: individual infection outcomes may depend on treatments received by others. Epidemiologists have defined the primary parameter of interest-called the "susceptibility effect"-as a contrast in infection risk under treatment versus no treatment, while holding exposure to infectiousness constant. A related quantity-the "direct effect"-is defined as an unconditional contrast between the infection risk under treatment versus no treatment. The purpose of this paper is to show that under a widely recommended randomization design, the direct effect may fail to recover the sign of the true susceptibility effect of the intervention in a randomized trial when outcomes are contagious. The analytical approach uses structural features of infectious disease transmission to define the susceptibility effect. A new probabilistic coupling argument reveals stochastic dominance relations between potential infection outcomes under different treatment allocations. The results suggest that estimating the direct effect under randomization may provide misleading conclusions about the effect of an intervention-such as a vaccine-when outcomes are contagious. Investigators who estimate the direct effect may wrongly conclude an intervention that protects treated individuals from infection is harmful, or that a harmful treatment is beneficial.

Citing Articles

Pairwise Accelerated Failure Time Regression Models for Infectious Disease Transmission in Close-Contact Groups With External Sources of Infection.

Sharker Y, Diallo Z, KhudaBukhsh W, Kenah E Stat Med. 2024; 43(27):5138-5154.

PMID: 39362790 PMC: 11583957. DOI: 10.1002/sim.10226.


Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs.

Buchanan A, Katenka N, Lee Y, Wu J, Pantavou K, Friedman S Pathogens. 2023; 12(2).

PMID: 36839598 PMC: 9967280. DOI: 10.3390/pathogens12020326.


Identification of causal intervention effects under contagion.

Cai X, Loh W, Crawford F J Causal Inference. 2021; 9(1):9-38.

PMID: 34676152 PMC: 8528235. DOI: 10.1515/jci-2019-0033.


AVERAGE TREATMENT EFFECTS IN THE PRESENCE OF UNKNOWN INTERFERENCE.

Savje F, Aronow P, Hudgens M Ann Stat. 2021; 49(2):673-701.

PMID: 34421150 PMC: 8372033. DOI: 10.1214/20-aos1973.


Assortativity and Bias in Epidemiologic Studies of Contagious Outcomes: A Simulated Example in the Context of Vaccination.

Zivich P, Volfovsky A, Moody J, Aiello A Am J Epidemiol. 2021; 190(11):2442-2452.

PMID: 34089053 PMC: 8799903. DOI: 10.1093/aje/kwab167.

References
1.
Cauchemez S, Carrat F, Viboud C, Valleron A, Boelle P . A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med. 2004; 23(22):3469-87. DOI: 10.1002/sim.1912. View

2.
Hayden F, Gubareva L, Monto A, Klein T, Elliot M, Hammond J . Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med. 2000; 343(18):1282-9. DOI: 10.1056/NEJM200011023431801. View

3.
Cai X, Loh W, Crawford F . Identification of causal intervention effects under contagion. J Causal Inference. 2021; 9(1):9-38. PMC: 8528235. DOI: 10.1515/jci-2019-0033. View

4.
VanderWeele T, Tchetgen Tchetgen E . Effect partitioning under interference in two-stage randomized vaccine trials. Stat Probab Lett. 2011; 81(7):861-869. PMC: 3084013. DOI: 10.1016/j.spl.2011.02.019. View

5.
Longini Jr I, Hudgens M, Halloran M, Sagatelian K . A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines. Stat Med. 1999; 18(1):53-68. DOI: 10.1002/(sici)1097-0258(19990115)18:1<53::aid-sim996>3.0.co;2-0. View